Isocitrate dehydrogenase 1–snail axis dysfunction significantly correlates with breast cancer prognosis and regulates cell invasion ability
Authors:
- Wen-Shan LiuWLWen-Shan Liu
- Shih-Hsuan ChanSCShih-Hsuan Chan
- Hong-Tai ChangHCHong-Tai Chang
- Guan-Cheng LiGLGuan-Cheng Li
- Ya-Ting TuYTYa-Ting Tu
- Hui-Hwa TsengHTHui-Hwa Tseng
- Ting-Ying FuTFTing-Ying Fu
- Hui-Yu ChangHCHui-Yu Chang
- Huei-Han LiouHLHuei-Han Liou
- Luo-Ping GerLGLuo-Ping Ger
- Kuo-Wang TsaiKTKuo-Wang Tsai
Open Access
- 16 April 2018
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 20 (1) , 25
Abstract
The isocitrate dehydrogenase (IDH) gene family expresses key functional metabolic enzymes in the Krebs cycle and mediates the epigenetic reprogramming, which serves as an important biomarker of breast cancer. However, the expression levels of the IDH protein and their biological function in human breast cancer remain largely unknown. In this study, the clinical impact of IDH1 expression on the progression and prognosis of breast cancer was evaluated using immunohistochemistry assay (IHC) of the corresponding tumor-adjacent normal, ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC) tissues from 309 patients with breast ductal carcinoma. The relationship between microRNA (miRNA) and IDH1 were examined by a bioinformatics approach, western blot and reporter assay. The biological functions of IDH1 were examined in breast cancer cells with IDH1 knockdown, including proliferation, migration and invasion. The present findings revealed that the mRNA and protein expression levels of IDH1 were both significantly lower in breast cancer tissues than in adjacent normal tissues. A low expression level of IDH1 in breast cancer significantly correlated with advanced stage (p = 0.012), lymph node metastasis (p = 0.018), and poor disease-specific survival (DSS) (adjusted hazard ratio (AHR), 1.57, 95% confidence interval (CI), 1.08–2.30; p = 0.02). Furthermore, oncogenic miR-32 and miR-92b were identified to suppress IDH1 expression, leading to the inhibition of cell migration and invasion. We further explored whether reduced expression of IDH1 significantly increases snail expression by activating HIFα (hypoxia-inducible factor-1 alpha) and NFκB (nuclear factor kappa B) signaling. Multivariate Cox regression analysis revealed that the combination of low IDH1 and high snail expression could be an independent risk factor for shorter DSS (AHR, 2.34; 95% CI, 1.32–4.16; p = 0.004) and shorter disease-free survival (AHR, 2.50; 95% CI, 1.39–4.50; p = 0.002) in patients with breast cancer. Our findings revealed that a IDH1low/Snailhigh molecular signature could serve as an independent biomarker for poor prognosis in breast cancerKeywords
Funding Information
- Kaohsiung Veterans General Hospital (VGHKS106-118, VGHKS106-174 and VGHKS107-171)
This publication has 45 references indexed in Scilit:
- Integrin α6 promotes esophageal cancer metastasis and is targeted by miR-92bOncotarget, 2016
- Oncometabolites‐driven tumorigenesis: From genetics to targeted therapyInternational Journal of Cancer, 2014
- Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to HypoxiaPLOS ONE, 2013
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-HydroxyglutarateCancer Cell, 2010
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1αScience, 2009
- MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)Journal of Biological Chemistry, 2007
- Oxalomalate, a competitive inhibitor of NADP+-dependent isocitrate dehydrogenase, regulates heat shock-induced apoptosisBiochemical and Biophysical Research Communications, 2005
- Molecular portraits of human breast tumoursNature, 2000
- The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysisNature, 1999